| Hans-Günter Meyer-Thompson | Naloxon
USA. FDA Approves Higher Dosage of Naloxone Nasal Spray to Treat Opioid Overdose
USA. FDA Approves Higher Dosage of Naloxone Nasal Spray to Treat Opioid Overdose
FDA Approves Higher Dosage of Naloxone Nasal Spray to Treat Opioid Overdose
The U.S. Food and Drug Administration announced today the approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose. The newly approved product delivers 8 milligrams (mg) of naloxone into the nasal cavity. The FDA had previously approved 2 mg and 4 mg naloxone nasal spray products. (FDA, USA, 30.04.2021)
https://www.fda.gov/news-events/press-announcements/fda-approves-higher-dosage-naloxone-nasal-spray-treat-opioid-overdose